The U.K. government is defending its negotiations with AstraZeneca (AZN), after the pharmaceutical company dropped a planned $558M investment last week, citing a shortfall in government funding, Vishala Sri-Pathma and Oliver Smith of BBC News report. Science minister Sir Chris Bryant told Parliament that the government had made a “significant offer” of support to the firm, but doing more “simply didn’t add up for the taxpayer” and that AstraZeneca’s decision had been “deeply disappointing.” The project would have seen an expansion of AstraZeneca’s vaccine manufacturing plant in Speke, Merseyside, the report notes.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio